Statins for everybody? New evidence on the efficacy and safety of the inhibitors of HMG Co-A reductase.

American journal of therapeutics

Volumn 10, Issue 6, 2003, Pages 423-428

  Alcocer, Luis ^a  

^a SECRETARÍA DE SALUD   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM;

CHOLESTEROL, LDL; CONTROLLED CLINICAL TRIALS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; RESEARCH DESIGN; RISK FACTORS;

EID: 2142700974     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200311000-00008     Document Type: Review

References (26)